Search - tctmd.com

Displaying 81 - 100 of 107

Sort: Relevancy | Date

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

L.A. McKeown

March 25, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Daily News

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

L.A. McKeown

December 07, 2020

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

L.A. McKeown

November 18, 2020

News Daily News

Heart Failure Doubles Risk of Dying From COVID-19

L.A. McKeown

October 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

Advertisement

July/August 2021 News Roundup

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

FDA Approves Dapagliflozin for CKD Patients

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

FDA Approves Vericiguat for High-risk Patients With HF

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

December 2020 News Roundup

TCTMD’s Top 10 Most Popular Stories for November 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

Heart Failure Doubles Risk of Dying From COVID-19

TCTMD’s Top 10 Most Popular Stories for September 2020

Dapagliflozin Wins in Patients With CKD

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

August 2020 News Roundup

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content